SVP Head of OMICs (all genders)

Evotec WD; Hamburg; On-site; EUR 180,000 - 240,000; Full time

Job summary

Evotec seeks a SVP Head of OMICs to lead Genomics, Transcriptomics, Proteomics, Metabolomics, and Multi-Omics Imaging, driving strategic direction and scientific excellence across Omics domains.

The role reports to the Drug Discovery Platform (DDP) leadership and requires defining OMICs strategy, managing budgets and P&L, and collaborating with Bioinformatics, AI/ML, Therapeutic Areas, and Translational Biomarkers, with international travel.

Qualifications

• PhD in Biochemistry, Biology, Chemistry, or a related scientific discipline.
• More than 20 years of experience in biotechnology or pharmaceutical R&D.
• Significant experience leading large scientific teams (20+ employees), ideally across multiple OMICs domains.
• Demonstrated leadership excellence with experience managing large, diverse, international scientific teams.
• Deep expertise in proteomics and transcriptomics, with a strong track record applying OMICs technologies to drug discovery.
• Strong understanding of multi-omics integration and biomarker discovery approaches.
• Solid knowledge of profit & loss management and operational performance metrics.
• Exceptional communication and organizational skills, with the ability to collaborate effectively across internal functions and with external partners.
• Proven ability to deliver high-quality results reliably, independently, and on time.
• Strong team orientation and ability to foster a collaborative, high-performance culture.

Responsibilities

• Lead all OMICs data-generation departments, including Genomics, Transcriptomics, Proteomics, Metabolomics, and Multi-Omics Imaging.
• Define, drive, and make decisions on the strategic application of OMICs technologies in drug discovery and biomarker development.
• Identify, evaluate, and implement new OMICs methodologies and platforms to maintain scientific and technological leadership.
• Ensure strong alignment and collaboration with key partner functions, including Bioinformatics & AI/ML, Therapeutic Areas, and Translational Biomarkers.
• Own budget planning for the OMICs sub-segment and be accountable for its profit & loss performance.
• Partner with the Commercial organization to shape the strategy for externalization and commercialization of OMICs platforms.
• Represent Evotec’s OMICs capabilities in client meetings, scientific congresses, and strategic external engagements.
• Contribute to the overall scientific and business strategy as a member of the Drug Discovery Platform (DDP) leadership team.

Skills

Strategic leadership

Biotech/Pharma R&D

Proteomics expertise

Transcriptomics expertise

Multi-omics integration

Team leadership

Communication & collaboration

Education

PhD in Biochemistry/Biology/Chemistry or related

Job description

About Evotec

Evotec is a life science company driving the discovery and development of highly effective therapeutics through world-class science and technology platforms. By combining cutting-edge research capabilities with deep expertise across multiple therapeutic areas, Evotec partners with pharmaceutical, biotechnology, and academic organizations worldwide to accelerate the development of innovative medicines for patients. As SVP Head of OMICs, you will provide strategic, scientific, and operational leadership for Evotec's OMICs organization, encompassing Genomics, Transcriptomics, Proteomics, Metabolomics, and Multi-Omics Imaging capabilities. Reporting into the Drug Discovery Platform (DDP) leadership team, you will play a key role in shaping the future direction of Evotec's OMICs strategy, enabling innovative drug discovery programs and biomarker development across the organization and for external partners. This leadership position can be based in Toulouse, France, Hamburg, Germany, or at another major Evotec location in Europe, depending on the successful candidate's profile and business needs. Regular international travel and close collaboration with Evotec's global scientific teams are expected.

Responsibilities

• Lead all OMICs data-generation departments, including Genomics, Transcriptomics, Proteomics, Metabolomics, and Multi-Omics Imaging
• Define, drive, and make decisions on the strategic application of OMICs technologies in drug discovery and biomarker development
• Identify, evaluate, and implement new OMICs methodologies and platforms to maintain scientific and technological leadership
• Ensure strong alignment and collaboration with key partner functions, including Bioinformatics & AI/ML, Therapeutic Areas, and Translational Biomarkers
• Own budget planning for the OMICs sub-segment and be accountable for its profit & loss performance
• Partner with the Commercial organization to shape the strategy for externalization and commercialization of OMICs platforms
• Represent Evotec’s OMICs capabilities in client meetings, scientific congresses, and strategic external engagements
• Contribute to the overall scientific and business strategy as a member of the Drug Discovery Platform (DDP) leadership team

Qualifications

• PhD in Biochemistry, Biology, Chemistry, or a related scientific discipline
• More than 20 years of experience in biotechnology or pharmaceutical R&D
• Significant experience leading large scientific teams (20+ employees), ideally across multiple OMICs domains
• Demonstrated leadership excellence with experience managing large, diverse, international scientific teams
• Deep expertise in proteomics and transcriptomics, with a strong track record applying OMICs technologies to drug discovery
• Strong understanding of multi-omics integration and biomarker discovery approaches
• Solid knowledge of profit & loss management and operational performance metrics
• Exceptional communication and organizational skills, with the ability to collaborate effectively across internal functions and with external partners
• Proven ability to deliver high-quality results reliably, independently, and on time
• Strong team orientation and ability to foster a collaborative, high-performance culture

Diversity and Inclusion

FR: Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap.

EN: In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.

IT: In compliance with fundamental ethical and professional principles and with Legislative Decree 198/2006, Evotec is an Equal Opportunity Employer committed to fostering a safe, diverse, and inclusive workplace built on mutual respect. We provide equal employment opportunities to all qualified candidates and employees based on their skills, experience, and professional qualifications. In line with our ethical and professional principles, all employment-related decisions, including recruitment and selection processes, are made fairly and without any form of discrimination. All qualified candidates will be considered for employment regardless of race, color, sex, age, disability, genetic information, gender expression, gender identity, nationality, religion, sexual orientation, or any other characteristic protected under applicable law.

Company Overview

Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company's multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this "Data-driven R&D Autobahn to Cures" for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases. Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development. Evotec operates globally with more than 5,000 highly qualified people. The Company's 17 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence.

For additional information please go to www.evotec.com and follow us on X/Twitter @Evotec and LinkedIn.